Featured
-
APIs | Breaking News | Industry News
Almac Awarded $1M BMGF Grant
Will work to develop novel biocatalytic routes to Etonorgestrel and Levonorgestrel APIs12.06.19
-
CRO News
Vivera Pharma, Parexel Ink Clinical Services Agreement
Parexel to conduct Phase I study to evaluate the bioavailability of TABMELT technology and provide regulatory support for Vivera's IND12.06.19
-
Breaking News | Drug Delivery | Industry News
MedPharm Triples Capacity at RTP Site
Invests $4M to expand topical and transdermal services in Durham, NC12.06.19
-
Breaking News | Drug Development | Trials & Filings
UCB Trial Achieves Endpoints
Phase III study met its co-primary and secondary endpoints demonstrating superiority of bimekizumab to Abbvie’s Humira in plaque psoriasis12.06.19
-
Analytical Services | Breaking News | Industry News | Vials
Stevanato Group Begins Construction on TEC
New facility supports company’s U.S.-centric biopharma drug development operations12.05.19
-
Breaking News | cGMP Manufacture | Industry News
Thermo Fisher Opens $90M Viral Vector Mfg. Site
The facility will create 200 new jobs and support the development, testing and manufacture of viral vectors.12.05.19
-
Breaking News | Promotions & Moves
Wes Wheeler to Lead UPS Healthcare and Life Sciences Unit
Wheeler will expand UPS's HCLS services.12.05.19
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Recipharm, RedHill Biopharma Ink Commercial Mfg. Pact
CDMO to provide commercial manufacturing to support Talicia launch following FDA approval.12.04.19
-
Breaking News | Facilities | Industry News
PCI Completes Expansion of Specialty Drug Product Capabilities
Increases capacity at Rockford, IL facility in response to growing market needs.12.04.19
-
Breaking News | Formulation Development | Industry News
Catalent, Ethicann Partner on Fast-Dissolve Treatment
Will leverage Catalent’s Zydis ODT technology to develop a new pharmaceutical-grade CBD and THC product to treat spasticity in MS patients12.03.19
-
Breaking News | Clinical Trials | CRO News | Drug Development
PPD Expands Early Development Research Capabilities
Adds neuroscience and ethno-bridging expertise, broadening capabilities to provide increased access to patients and special populations at its CRUs12.03.19
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | GMPs/GCPs | Industry News
CureVac Granted Mfg. Authorization for GMP Production Suite
GMP Production Suite scales up capacity for preclinical, clinical and early launch needs for proprietary and partnered programs12.03.19
-
Breaking News | cGMP Manufacture | Drug Development | Industry News
Piramal, BerGenBio Partner on Leukemia Drug
Piramal to leverage its Xcelerate Integrated Solutions platform and is expected to provide commercial manufacturing of the final product12.03.19
-
Breaking News | Collaborations & Alliances
Appili, Saptalis Enter Commercial Pact
Saptalis to oversee the regulatory review, manufacturing and preparation for the anticipated commercialization of ATI-1501 in the U.S.12.03.19
-
Breaking News | Drug Development | Drug Discovery | Industry News
Lilly Opens Shared Innovation Lab
Aims to speed the discovery of innovative medicines through collaboration with local biotech companies12.02.19
- CDMOs to Benefit From Rising BTDs, Orphan Drugs and Fast Track Status
- Stevanato, Duoject Enter Auto-injector Collaboration
- Thermo Fisher Bolsters China Presence
- C2 Pharma Expands API Portfolio
- CPhI’s 16th Pharma Awards Winners
- MilliporeSigma Licenses CRISPR Technology to Evotec
- West and SCHOTT Enter Packaging Partnership
- IDT Biologika, NIH Mfg. Contract Updated
- Parsolex Selects Bosch Packaging Technology for New cGMP Facility
- Lonza Selects Cryoport as Preferred Partner
- MilliporeSigma Launches New Sucrose Offering
- Novel Surfactant Excipient Improves Biologic Stability in Liquid Formulation
- Cell and Gene Therapy Landscape
- MilliporeSigma Licenses CRISPR Technology to Evotec
- MilliporeSigma Launches Parteck COAT Excipient
- AAPS PharmSci360 2019
- Lonza Selects Cryoport as Preferred Partner
- Vineti, WuXi AppTec Ink Personalized Therapy Management Platform Pact
- Catalent Biologics Launches GPExR Boost Cell Line Expression Technology
- Recipharm Divests Bioanalysis Biz
- Almac Awarded $1M BMGF Grant
- Vivera Pharma, Parexel Ink Clinical Services Agreement
- MedPharm Triples Capacity at RTP Site
- UCB Trial Achieves Endpoints
- PhRMA Appoints Federal Advocacy SVP
- CStone Hires Shirley Zhao as GM
- Stevanato Group Begins Construction on TEC
- Bayer, CHOP Partner to Develop Oral NRT
- Novasep Launches oXYgene for Boosting Viral Vector Production
- Thermo Fisher Opens $90M Viral Vector Mfg. Site
November/December 2019
- Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI
- Transitioning from Clinical Production to Commercial Manufacturing
- Clinical Trial Technology
- Regenerative Medicine: Overcoming the supply chain challenges
- The Future of the Pharmaceutical Supply Chain
- Challenges and Opportunities in Vaccines Drug Development
- Managing Partnerships: Sponsors & CDMOs
- Towards Sunset or a New Dawn?
- Biopharma Over 20 Years
Contract Service Directory
Search the Directories for A Company:
